STAAR Surgical (STAA) Misses Q4 EPS by 1c, provides guidance
Get Alerts STAA Hot Sheet
Price: $22.61 +0.53%
EPS Growth %: -72.2%
Financial Fact:
Other income (expense), net: 8K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: -72.2%
Financial Fact:
Other income (expense), net: 8K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $76.3 million versus the consensus estimate of $75.94 million.
GUIDANCE:
STAAR Surgical sees FY2024 revenue of $335-340 million, versus the consensus of $337.7 million. Adjusted EBITDA of approximately $36 million and Adjusted EBITDA per diluted share of approximately $0.70.2
For earnings history and earnings-related data on STAAR Surgical (STAA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- AMTD Digital reports $1.2B in total assets, $42.4M profit
- AI-powered cyber threats light a fire under cybersecurity stocks
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share